Filed: 11/12/2024ACC: 0001104659-24-116643
📋 What this filing means
CATALYS PACIFIC, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $125.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$125.40M
Total AUM (reported)
10M
Total Shares
Allocation by class
COM$125.40M100.0%
Portfolio Concentration
Top 3$125.40M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10M
Sole
Full voting authority
10M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Mineralys Therapeutics, Inc.
SOLEShares8.64M
TypeSH
Market value$104.69M
83.48%
Sole
8.64M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares1.12M
TypeSH
Market value$20.30M
16.19%
Sole
1.12M
Shared
0.00
None
0.00
HilleVax, Inc.
SOLEShares236.38K
TypeSH
Market value$416.0K
0.33%
Sole
236.38K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc.SOLE | COM | 8.64M | SH | $104.69M 83.48% | 8.64M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 1.12M | SH | $20.30M 16.19% | 1.12M | 0.00 | 0.00 |
HilleVax, Inc.SOLE | COM | 236.38K | SH | $416.0K 0.33% | 236.38K | 0.00 | 0.00 |